Columbia Neurologist Lawrence S. Honig, MD, PhD comments about the new Alzheimer's blood testing study and how its findings could be useful, but up to a point.
Dr. Miguel Arce Rentería, a neuropsychologist at Columbia University, comments that treatment that focuses on social issues may hold off the worst of Alzheimer’s Disease for years.
Neuropsychologist Victoria M. Leavitt, PhD is featured in three EveryDay Health podcasts about recognizing and treating patients with mild cognitive impairment.
A new collaborative study by Drs. Martin Picard and Philip L. De Jager examines the potential link between the brain's mitochondria and a person's psychological stress.
Yaakov Stern, PhD, Florence Irving Professor of Neuropsychology in the Department of Neurology at Columbia University Irving Medical Center talks about his research on cognition and aging.
Researchers from the Columbia University Department of Neurology discovered a genetic variant that may reduce the odds of developing Alzheimer’s disease by up to 70%.
James Noble, MD, MS, Associate Professor of Neurology in the Taub Institute and the Sergievsky Center at CUMC discusses his diverse body of work and the motivation behind his passion projects.
Lawrence S. Honig, MD, PhD, Professor of Neurology at CUMC, comments on the suggestion that some people may have developed Alzheimer's disease after receiving growth hormones
Caghan Kizil, PhD, MSc, Associate Professor of Neurological Sciences in Neurology and in the Taub Institute, talks about using zebrafish as a model organism in his research.
Miguel Arce Rentería, PhD, Assistant Professor of Neuropsychology (in Neurology), speaks about factors that may contribute to an increased risk of developing dementia or Alzheimer's disease in Latinos
Caghan Kizil, PhD, MSc, Associate Professor of Neurological Sciences (in Neurology & in the Taub Institute) and colleagues discovered a mechanism that promotes neurogenesis in the zebrafish brain
Carol M. Troy, MD, PhD, Professor of Pathology & Cell Biology and Neurology at CUMC, discusses, based on a new study, how eye drops could be more effective in treating retinal vein occlusion